e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Pathobiology in experimental and neoplastic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Improving the tuberculous and malignant pleural effusions diagnosis. A low cost model based on a multivariate analysis
R. K. B. Sales, S. Marcia, F. S. Vargas, V. L. Capelozzi, L. R. Teixeira, M. Acencio, L. Antonangelo (Sao Paulo, Brazil)
Source:
Annual Congress 2004 - Pathobiology in experimental and neoplastic lung diseases
Session:
Pathobiology in experimental and neoplastic lung diseases
Session type:
Thematic Poster Session
Number:
617
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. K. B. Sales, S. Marcia, F. S. Vargas, V. L. Capelozzi, L. R. Teixeira, M. Acencio, L. Antonangelo (Sao Paulo, Brazil). Improving the tuberculous and malignant pleural effusions diagnosis. A low cost model based on a multivariate analysis. Eur Respir J 2004; 24: Suppl. 48, 617
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
A comparative study of conventional cytology and cell block method in the diagnosis of malignant pleural effusion.
Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment
Year: 2018
Diagnostic value of combined assays in differentiating tuberculous and malignant pleural effusions
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
Algorithm for diagnostics of recurrent pleural effusions suspected to malignancy
Source: Eur Respir J 2006; 28: Suppl. 50, 88s
Year: 2006
In search of an ideal method to diagnose tuberculous pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 612s
Year: 2006
Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
An algorithm for the investigation of isolated suspected malignant pleural effusions
Source: Eur Respir J 2003; 22: Suppl. 45, 541s
Year: 2003
Breath analysis allows to predict treatment response in malignant pleural mesothelioma patients.
Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease
Year: 2021
Diagnostic performance of novel and rapid tests for the diagnosis of tuberculous pleural effusions
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Clinical and laboratorial variables useful in the differential diagnosis of pleural effusions secondary to tuberculosis or lymphoma
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011
Ideal volume sampling in the diagnosis of malignant pleural effusions
Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions
Year: 2012
Optimal management of symptomatic malignant pleural effusions: individualised care
Source: Virtual Congress 2021 – Hot news from the pleura
Year: 2021
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020
A comparative study of conventional cytology and cell block method in the diagnosis of pleural effusion
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Retrospective analysis of survival time in malignant pleural effusion requiring IPC insertion
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
The use of immunocytochemistry to diagnose the etiology of malignant pleural effusion.
Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Year: 2018
Malignant pleural effusions: diagnosis and management
Source: International Congress 2017 – PG5 Pleural disease management
Year: 2017
Malignant pleural effusions: from the diagnosis to the management
Source: International Congress 2015 – ME2 Malignant pleural effusions: from diagnosis to management
Year: 2015
Predictors of survival in patients with recurrent malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept